1. Systematic review and meta-analysis of single-dose and non-single-dose methotrexate protocols in the treatment of ectopic pregnancy.
- Author
-
Yuk JS, Lee JH, Park WI, Ahn HS, and Kim HJ
- Subjects
- Female, Humans, Pregnancy, Randomized Controlled Trials as Topic, Clinical Protocols, Methotrexate administration & dosage, Methotrexate therapeutic use, Pregnancy, Ectopic drug therapy
- Abstract
Background: It remains unclear which methotrexate protocol for the treatment of ectopic pregnancy has a higher success rate or a higher adverse effect rate., Objective: To compare the treatment success rates and adverse effect rates of single-dose and non-single-dose (two-dose and multi-dose) methotrexate protocols in the treatment of ectopic pregnancy., Search Strategy: Various databases including Medline, Embase, and the Cochrane Central Register of Controlled Trials were searched on July 1, 2017, using search terms including "methotrexate" and "pregnancy.", Selection Criteria: Randomized controlled trials comparing different methotrexate protocols for the treatment of ectopic pregnancy were included., Data Collection and Analysis: Relative risks (RRs) and 95% confidence intervals (CIs) were calculated to compare treatment success rates and adverse effect rates., Main Results: The single-dose and non-single-dose protocols had similar success rates (RR 1.00, 95% CI 0.96-1.04; 11 trials, 1121 patients, I
2 =18%). The non-single-dose protocols had a higher adverse effect rate than did the single-dose protocol (RR 0.73, 95% CI 0.59-0.91; nine trials, 934 patients, I2 =0%)., Conclusions: The single-dose methotrexate protocol was the optimal protocol for the medical treatment of ectopic pregnancy., (© 2018 International Federation of Gynecology and Obstetrics.)- Published
- 2018
- Full Text
- View/download PDF